Vaccine equity: Past, present, and future
Publication date
2022-03-15
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.
Keywords
COVID-19 Vaccines/therapeutic use, COVID-19/epidemiology, Health Equity, Humans, Pandemics/prevention & control, Vaccines/therapeutic use, General Biochemistry,Genetics and Molecular Biology, General Medicine, News
Citation
van der Graaf, R, Browne, J L & Baidjoe, A Y 2022, 'Vaccine equity : Past, present, and future', Cell reports medicine, vol. 3, no. 3, 100551, pp. 1-4. https://doi.org/10.1016/j.xcrm.2022.100551